Raltegravir potassium salt ≥98%, crystalline solid
Leverancier: Cayman Chemical
Ratings:
(No Reviews)
Total Ratings: 0
Avg. Ratings: 0.0 out of 5
|
Gevaar
|
Synoniemen:
Raltegravir potassium, Potassium 4-((4-fluorobenzyl)carbamoyl)-1-methyl-2-(2-(5-methyl-1,3,4-oxadiazole-2-carboxamido)propan-2-yl)-6-oxo-1,6-dihydropyrimidin-5-olate
16071-10
16071-1
16071-50
16071-5
CAYM16071-10EA
361
EUR
CAYM16071-10
CAYM16071-1
CAYM16071-50
CAYM16071-5
Raltegravir potassium salt ≥98%, crystalline solid
Raltegravir potassium salt
Raltegravir is a potent, selective, and orally bioavailable inhibitor of HIV integrase (IC50 = 15 nM).
It is metabolised primarily by uridine diphosphate glucuronosyltransferase 1A1. Raltegravir has long-term efficacy and safety in managing HIV-1 infection in adults, children, and adolescents.
Formule:
C₂₀H₂₀FKN₆O₅ MW: 482.51 g/mol Bewaar temperatuur: Koelkast |
MDL Nummer:
MFCD12031642 CAS nummer: 871038-72-1 |
Specification Test Results
Purity | ≥98% |
λmax | 210, 312 nm |
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...